Table III.
Effect of different treatment on the expression levels of TNF-α in multiple organs at 3 h (pg/ml).
| Organ | C | SAP | SL | IU | UL |
|---|---|---|---|---|---|
| Pancreas | 4.497±0.275 | 12.153±0.398a | 5.535±0.260a,b | 6.651±0.213a,b | 5.287±0.334a,b |
| Lung | 11.126±1.513 | 21.383±1.834a | 14.219±1.002a,b | 15.670±1.614a,b | 12.870±1.412b,c |
| Liver | 11.079±0.566 | 25.054±0.605a | 12.797±0.842a,b | 15.009±0.866a,b | 12.929±0.745a,b |
| Kidney | 9.587±0.405 | 14.566±0.355a | 10.802±0.538a,b | 12.403±0.731b,c | 10.082±0.436a,b |
Values are presented as mean ± standard deviation.
a
P<0.01 vs. group C;
b
P<0.01 vs. group SAP;
c
P<0.05 vs. group C. C, control; SAP, severe acute pancreatitis; SL, saline lavage; IU, intravenous ulinastatin; UL, ulinastatin lavage; TNF-α, tumor necrosis factor.